深部脑刺激的概率映射:15年治疗的见解
该研究利用15年多疾病DBS数据集(482例,含帕金森病303例、肌张力障碍64例、震颤39例、难治性抑郁/神经性厌食76例),构建概率刺激图(PSM)识别最佳临床反应的神经解剖基础。结果显示PSM与个体激活体积的重叠可预测临床结局,但非唯一决定因素。未来个体化模型结合映射技术与患者临床变量有望优化靶点选择。
要点
- PSM与个体激活体积重叠可预测DBS临床结局。
- 重叠并非DBS反应的唯一决定因素。
- 个体化模型有望优化DBS靶点选择。
核心结论
- PSM与个体激活体积的重叠可指导预测临床结局,但不是反应的唯一决定因素。
研究设计与样本
- 回顾性多疾病DBS数据集,共482例,其中帕金森病303例、肌张力障碍64例、震颤39例、难治性抑郁/神经性厌食76例。
- 使用高分辨率结构MRI和激活体积建模生成概率刺激图(PSM)。
主要发现
- PSM delineated areas of above-mean and below-mean response for each patient cohort。
- PSM与个体患者激活体积的重叠可预测临床结局,但非唯一决定因素。
临床怎么用
- PSM重叠可作为预测DBS临床结局的参考,但需考虑其他因素。
- 未来个体化模型可能优化DBS靶点选择。
局限性
- 回顾性研究设计。
- PSM重叠不是DBS反应的唯一决定因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deep brain stimulation (DBS) depends on precise delivery of electrical current to target tissues. However, the specific brain structures responsible for best outcome are still debated. We applied probabilistic stimulation mapping to a retrospective, multidisorder DBS dataset assembled over 15 years at our institution (ntotal = 482 patients; nParkinson disease = 303; ndystonia = 64; ntremor = 39; ntreatment-resistant depression/anorexia nervosa = 76) to identify the neuroanatomical substrates of optimal clinical response. Using high-resolution structural magnetic resonance imaging and activation volume modeling, probabilistic stimulation maps (PSMs) that delineated areas of above-mean and below-mean response for each patient cohort were generated and defined in terms of their relationships with surrounding anatomical structures. Our results show that overlap between PSMs and individual patients' activation volumes can serve as a guide to predict clinical outcomes, but that this is not the sole determinant of response. In the future, individualized models that incorporate advancements in mapping techniques with patient-specific clinical variables will likely contribute to the optimization of DBS target selection and improved outcomes for patients. ANN NEUROL 2021;89:426-443.
引用
- Elias GJB, Boutet A, Joel SE, et al. Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy. Ann Neurol. 2020. PMID: 33252146. doi:10.1002/ana.25975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。